Evaluation of prevalence of cervical and breast cancer screening programs between gynecologists

Iranian Journal of Obstetrics, Gynecology and Infertility

Volumn 13, Issue 1, 2010, Pages 1-6

  Alavi, Ghodsieh ^a   Hoseininejad, Javad ^a   Masoom, Asieh Sadat Fattahi ^a   Shakeri, Mohammad Taghi ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Cervical cancer; Gynecologists; Screening test

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; EVALUATION; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PAPANICOLAOU TEST; QUESTIONNAIRE; SCREENING TEST; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

EID: 77953386117     PISSN: 16802993     EISSN: 20082363     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. NHS cancer screening program. Breast srceening: the facts [Online]. 2009 [cited 2009 Feb 10]; [12 screen]. Available from: URL: http://www. cancerscreening.nhs.uk/breastscreen/publications/nhsbsp-the-facts-english-2009. pdf
2. American cancer society (ACS). The national breast and cervical cancer early detection program (NBCCEDP) [Online]. 2009 Sep 22 [cited 2009 Feb 10]; [9 screen]. Available from: URL: http://www.cancer.org/docroot/PED/content/PED-1- 5X-CDC-Collaboration.asp
3. Centers for Disease Control and Prevention. Cancer Prevention and Control [Online]. 2009 [cited 2009 Feb 10]; Available from: URL: http://www.cdc.gov/ cancer/
4. Dinshaw K, Mishra G, Shastri S. Determinants of compliance in a cluster randomized controlled trial on screening of breast and cervix cancer in Mumbai, India. Oncology 2007;73(3-4):154-161
5. Heidari Z, Mahmoudzadeh-sagheb HR, Sakhavar N. Breast cancer screening knowledge and practice among women in southeast of Iran. Acta Medica Iraninca 2008;46(4):321-328
6. th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p.612.
7. Carranza-lira S, Gooch AL, Saldivar N, Osterwalder MS. Climacteric symptom control after the addition of low dose esterified conjugated estrogen to raloxifene standard doses. Int J Fertile Womens Med 2007;52(2-3):93-96
8. Berek JS. Berek and Novak gyencology. 14 ed. Philadelphia: Lippincott Williams &Wilkins; 2007. p.1608.
9. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the united states, 2009: a review of current American cancer society guidelines and issues in cancer screening. CA Cancer J Clin 2009;59(1):27-41.
10. Allahverdipour H, Emami A. Perceptions of cervical threat, benefits and barriers of Papanicolaou smear screening programs for women in Iran. Women Health 2008;47(3):23-37.
11. Samuel PS, Pringle JP, James NW 4th, Fielding SJ, Fairfield KM. Breast, cervical and colorectal cancer screening rates among female Cambodian, Somali and Vietnamess immigrants in the USA. Int J Equity Health 2009;8:30.
12. Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in great Britain: analysis of cross sectional survey data. BMJ 2009;338:b2025.